Refractive error and visual impairment in Ireland schoolchildren.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
08 2019
Historique:
received: 17 05 2018
revised: 03 08 2018
accepted: 15 09 2018
pubmed: 14 10 2018
medline: 14 2 2020
entrez: 14 10 2018
Statut: ppublish

Résumé

To report refractive error prevalence and visual impairment in Republic of Ireland (henceforth 'Ireland') schoolchildren. The Ireland Eye Study examined 1626 participants (881 boys, 745 girls) in two age groups, 6-7 years (728) and 12-13 years (898), in Ireland between June 2016 and January 2018. Participating schools were selected by stratified random sampling, representing a mix of school type (primary/postprimary), location (urban/rural) and socioeconomic status (disadvantaged/advantaged). Examination included monocular logarithm of the minimum angle of resolution (logMAR) presenting visual acuity (with spectacles if worn) and cycloplegic autorefraction (1% Cyclopentolate Hydrochloride). Parents completed a questionnaire to ascertain participants' lifestyle. The prevalence of myopia (spherical equivalent refraction (SER): ≤-0.50 D), hyperopia (SER: ≥+2.00 D) and astigmatism (≤-1.00 DC) among participants aged 6-7 years old was 3.3%, 25% and 19.2%, respectively, and among participants aged 12-13 years old was 19.9%, 8.9% and 15.9%, respectively. Astigmatic axes were predominately with-the-rule. The prevalence of 'better eye' presenting visual impairment (≥0.3 logMAR, with spectacles, if worn) was 3.7% among younger and 3.4% among older participants. Participants in minority groups (Traveller and non-white) were significantly more likely to present with presenting visual impairment in the 'better eye'. The Ireland Eye Study is the first population-based study to report on refractive error prevalence and visual impairment in Ireland. Myopia prevalence is similar to comparable studies of white European children, but the levels of presenting visual impairment are markedly higher than those reported for children living in Northern Ireland, suggesting barriers exist in accessing eye care.

Identifiants

pubmed: 30315130
pii: bjophthalmol-2018-312573
doi: 10.1136/bjophthalmol-2018-312573
pmc: PMC6678142
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112-1118

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ophthalmology. 2006 Sep;113(9):1567-73
pubmed: 16857261
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3764-70
pubmed: 12939289
Invest Ophthalmol Vis Sci. 2009 May;50(5):2011-7
pubmed: 19136705
Optom Vis Sci. 2016 Mar;93(3):227-34
pubmed: 26905537
Bull World Health Organ. 2008 Jan;86(1):63-70
pubmed: 18235892
Sci Rep. 2017 Feb 09;7:42187
pubmed: 28181990
Br J Ophthalmol. 2001 May;85(5):521-6
pubmed: 11316705
Br J Ophthalmol. 2010 Sep;94(9):1155-9
pubmed: 20494909
Optom Vis Sci. 2017 Sep;94(9):894-902
pubmed: 28816868
Arch Ophthalmol. 2008 Apr;126(4):527-30
pubmed: 18413523
Br J Ophthalmol. 2016 Jul;100(7):882-890
pubmed: 26802174
Invest Ophthalmol Vis Sci. 2011 Jun 08;52(7):4048-53
pubmed: 21372019
Optom Vis Sci. 1999 Dec;76(12):855-60
pubmed: 10612408
Am J Ophthalmol. 2000 Apr;129(4):421-6
pubmed: 10764848
Arch Dis Child. 2005 Feb;90(2):150-3
pubmed: 15665167
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Ophthalmic Physiol Opt. 2007 Jan;27(1):60-5
pubmed: 17239191
PLoS One. 2016 Jan 19;11(1):e0146332
pubmed: 26783753
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4021-31
pubmed: 22562516
Int J Health Sci (Qassim). 2013 Nov;7(3):291-9
pubmed: 24533022
Ann Acad Med Singapore. 2004 Jan;33(1):27-33
pubmed: 15008558
Optom Vis Sci. 2004 Jan;81(1):56-61
pubmed: 14747762
Ophthalmology. 2013 Sep;120(9):1728-35
pubmed: 23631946
Ophthalmic Physiol Opt. 2011 Sep;31(5):550-8
pubmed: 21762431
J AAPOS. 2005 Dec;9(6):579-83
pubmed: 16414527
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):793-9
pubmed: 14985292
J Am Optom Assoc. 1997 Oct;68(10):648-50
pubmed: 9354056
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3858-63
pubmed: 18469186
Bull World Health Organ. 2009 Jun;87(6):431-7
pubmed: 19565121
Ophthalmic Physiol Opt. 2018 May;38(3):298-308
pubmed: 29691921
Surv Ophthalmol. 2010 Nov-Dec;55(6):539-60
pubmed: 20850856
Br J Ophthalmol. 2010 Sep;94(9):1150-4
pubmed: 20558427

Auteurs

Siofra Christine Harrington (SC)

School of Physics and Clinical and Optometric Sciences, College of Science and Health, Dublin Institute of Technology, Dublin, Ireland siofra.harrington@dit.ie.

Jim Stack (J)

Waterford Institute of Technology, Waterford, Ireland.

Kathryn Saunders (K)

School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland.

Veronica O'Dwyer (V)

School of Physics and Clinical and Optometric Sciences, Dublin Institute of Technology, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH